FENC · Fennec Pharmaceuticals Inc.
Market Cap
$430.27M
Shares
35.07M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-13 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-10 | — | |
| 8-K | 2026-05-22 | 2026-05-21 | |
| Investor Event Transcript | 2026-05-19 | 2026-06-30 | |
| Investor Event Transcript | 2026-05-19 | 2026-06-30 | |
| 8-K | 2026-05-18 | — | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 8-K | 2026-04-28 | 2026-04-27 | |
| DEF 14A | 2026-04-28 | 2026-06-10 | |
| 8-K | 2026-04-22 | — | |
| 8-K | 2026-04-07 | — | |
| 10-K | 2026-03-27 | 2025-12-31 | |
| 8-K | 2026-03-24 | — | |
| 8-K | 2026-03-16 | — | |
| 8-K | 2026-03-04 | — | |
| 8-K | 2026-02-20 | — | |
| 8-K | 2025-12-09 | — | |
| 8-K | 2025-12-02 | — | |
| 8-K | 2025-11-19 | 2025-11-13 | |
| 8-K | 2025-11-18 | 2025-11-17 | |
| 8-K | 2025-11-17 | 2025-11-13 | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-06-03 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| DEF 14A | 2025-04-25 | 2025-06-03 | |
| 10-K | 2025-03-26 | 2024-12-31 | |
| 8-K | 2025-03-10 | — | |
| 8-K | 2025-02-07 | — | |
| 8-K | 2024-12-20 | 2024-12-18 | |
| 8-K | 2024-12-20 | — | |
| 10-Q | 2024-11-08 | 2024-09-30 | |
| 8-K | 2024-10-30 | 2024-10-28 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-07 | 2024-08-05 | |
| 8-K | 2024-07-02 | 2024-06-30 | |
| 8-K | 2024-06-25 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| DEF 14A | 2024-05-13 | 2024-06-25 | |
| 8-K | 2024-05-09 | 2024-05-07 | |
| 10-K | 2024-03-29 | 2023-12-31 | |
| 8-K | 2024-03-25 | 2024-03-21 | |
| 8-K | 2024-03-21 | 2024-03-15 | |
| 8-K/A | 2024-03-06 | 2024-02-29 | |
| 8-K | 2024-02-29 | — | |
| 8-K | 2024-02-02 | 2024-02-01 | |
| 8-K | 2023-12-06 | 2023-12-04 | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-07 | 2023-11-06 |
Showing 1–50 of 103 filings
Key facts
CIK
1211583
CUSIP
31447P100
13F (30d)
90 filings
88 filers
Visit website
Investor relations